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Abstract: Three non-isoprenoid botryane sesquiterpenoids, named boledulins A–C (1–3), have been isolated from the cultures of 
basidiomycete Boletus edulis Bull. The structures were established by means of spectroscopic methods. Boledulin A (1) exhibited 
moderate inhibitory activity against five human cancer cell lines. 
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Introduction 
Botryane sesquiterpenoids possess a non-isopreniod system 
skeleton, which have been found limited to several fungi such 
as Botrytis cinerea1 and Daldinia concentrica2. The 
representative botryane sesquiterpenoids are botrydial1a and its 
derivatives, which are characterized from phytopathogenic 
fungus B. cinerea. These sesquiterpenoids showed a wide 
range of biological activities. For instance, they were 
responsible for the typical lesions associated with B. cinerea 
infection, and they played an important role in the 
pathogenicity of the organism in vivo.1c,3 Botryane 
sesquiterpenoids attracted great interests of chemists to carry 
out a large number of investigations including chemical 
transformations,3b structure-activity relationships,1c synthesis,4 
and biosynthesis5. Our group has long been focused on the 
chemical study on higher fungi. Recently, three new botryane 
sesquiterpeniods, boledulins A-C (1–3), have been isolated 
from cultures of Boletus edulis Bull, an edible basidiomycete 
collected from southwest of China. The structures were 
established by extensive spectroscopic data. It is noted that 
compound 3 is a 15-nor-botryane sesquiterpenoid which was 
seldom found previously. In addition, compounds 1–3 were 
evaluated for their cytotoxicity against five human cancer cell 
lines. This paper reports the isolation, structural elucidation, 
and cytotoxicity of these compounds. 
 
Results and Discussion 
Compound 1 was isolated as optical active white solid ([α]20D 
+ 16.8). HRESIMS displayed an [M + Na]+ peak at m/z 
337.1990 (calcd 337.1990 for C17H30O5Na) indicating a 
molecular formula C17H30O5 corresponding to three degrees of 
unsaturation. IR spectrum revealed the existence of hydroxy 
and carbonyl groups due to absorption bands at 3439 and 1729 
cm–1, respectively. The 13C NMR spectrum gave 17 carbon 
resonances (Table 1). Besides two methoxy signals at δC 51.6 
and 59.4, 15 resonances can be ascribable to four methyls, 
three sp3 methylenes, four sp3 methines, three sp3 quaternary 
carbons, and one sp2 quaternary carbon at δC 174.6. These data 
suggested that compound 1 might be a bicyclic 
sesquiterpenoid. 
In the HMBC spectrum, the correlation of a methoxy signal 
at δH 3.70 (3H, s) with δC 174.6 (s, C-10) established a methyl 
ester group. A key correlation of δH 2.45 (1H, d, J = 12 Hz, H-
1) with C-10 suggested the linkage of C-10 to the methine. 
Starting from this methine, a structural fragment was 
established by the analysis of 1H-1H COSY spectrum as shown 
in Figure 1. The HMBC correlations of H-1 and δH 1.56 (1H, d, 
J = 11.0 Hz, H-5) with the oxygen-containing quaternary 
carbon signal at δC 87.8 (s, C-9) revealed the connections of C-
9 to C-1 and C-5, respectively. Hence, ring A was established 
as shown in Figure 1. Ring B was readily built due to the rest 
of carbon and proton resonances leading to the only perfect 
linkage, which was supported further by the HMBC 
correlations (Figure 1). In addition, a methoxy group placed at 
 
*To whom correspondence should be addressed. E-mail: 
jkliu@mail.kib.ac.cn. 
30      T. FENG et al.                                                                                                                               Nat. Prod. Bioprospect. 2011, 1, 29–32 
 
         
C-15 was also deduced from the HMBC correlation (Figure 1). 
In the ROESY spectrum, the observed cross peaks of H-
1/H-5, H-2/H-4, H-1/CH3-11, H-4/CH3-12 and H-4/CH3-14 
suggested H-1, H-5, and Me-11 in the same side, while H-2, 
H-4, Me-12, and Me-14 in the opposite side. Further, these 
above ROESY cross peaks limited OH-9 to be the same side 
with H-1. Structurally, compound 1 should be a derivative of 
botrydial ([α] 20D  + 34),1a the first botryane sesquiterpenoid 
isolated from Botrytis cinerea,1a whose absolute configuration 
has been identified on the basis of synthesis and biosynthesis4-6. 
Accordingly, the absolute configuration of 1 could be 
determined as 1S, 2R, 4S, 5R, 8S, 9S. Therefore, the structure 
of 1 (boledulin A) was established. 
Compound 2 was isolated as a colorless oil, that gave an [M 
+ Na]+ peak at m/z 305.1720 (calcd for C16H26O4Na, 305.1728) 
in the positive ion HRESIMS, consistent with the molecular 
formula C16H26O4 indicating four degrees of unsaturation. The 
1D NMR spectroscopic data (Tables 1 and 2) suggested that 
the backbone of 2 was the same as that of 1. Differences 
between them were identified to be a new double bond (δC 
136.4 and 150.9) and the loss of a methoxy group at C-15 in 2. 
The HMBC correlations of δH 0.93 (3H, s, Me-14) with δC 
136.9 (s, C-9) and δH 1.16 and 1.34 (each 3H, s, Me-12 and 
Me-13, respectively) with δC 150.9 (s, C-5) suggested the 
double bond placed between C-5 and C-9. The HMBC 
correlations between H-1, H-4 and C-5, C-9 were also 
observed. Detailed analysis of other 2D NMR data confirmed 
that the other parts of 2 were the same as those of 1. Therefore, 
the structure of 2 (boledulin B) was established. 
Compound 3 was isolated as white solid. The molecular 
formula C14H24O2 was established by HREIMS at m/z 
224.1765 [M]+ (calcd for C14H24O2 at m/z 244.1776 [M]+) 
indicating three degrees of unsaturation. The 1H NMR 
spectrum displayed similar patterns to those of 1 and 2 
including clear signals for four methyl signals (three singlets 
and one doublet) (Table 2). The 13C NMR spectrum revealed 
14 carbon resonances ascribable to four sp3 methyls, three sp3 
methylenes, four sp3 methines, one sp3 quaternary carbon, and 
two sp2 quaternary carbons (Table 1). These data suggested 
that compound 3 might be a bicyclic nor-sesquiterpenoid. 
The 13C NMR signal at C 60.5 (t, C-10) allowed the 
existence of an oxygen-containing methylene, and starting 
from which, two structural fragments of CH3CH- and 
CH2CHCHCH2CHCH- were established by the 1H–1H COSY 
spectrum as shown in Figure 1. In the HMBC spectrum, the 
key correlations of δH 1.83 (1H, m, H-1) with C 131.4 (s, C-9) 
and δH 2.04 (1H, d, J = 6.4 Hz, H-5) with C 131.4 (s, C-9) 
suggested the link of C-9 to C-1 and C-5, respectively. Hence, 
the structure of ring A was established. The HMBC correlation 
Table 2. 1H NMR Data for Boledulins A-C (1-3). 
position 1a 2b 3b
1 2.45, d (12.0) 2.97, d (6.0) 1.83, m 
2 1.92, m 1.89, m 1.60, m 
3a 
3b 











(10.4, 6.4, 2.0) 
5 1.56, d (11.0)  2.04, d (6.4) 
7 1.15, d (12.8) 
2.42, d (12.8) 
1.49, d (13.2) 
1.98, d (13.2) 
2.05, d (16.8) 
2.19, d (16.8) 
10   3.81, dd (11.6, 4.8) 
4.07, dd (11.6, 3.3) 
11 0.87, d (6.6) 0.95, d (6.6) 1.00, d (6.4) 
12 1.28, s 1.16, s 1.08, s 
13 1.26, s 1.34, s 1.17, s 
14 0.97, s 0.93, s 1.78, s 
15a 
15b 
3.01, d (10.2) 
3.31, d (10.2) 
3.07, d (10.4) 
3.09, d (10.4) 
 
COOCH3 3.70, s 3.69, s  
OCH3 3.27, s   
aRecorded in CDCl3 at 400 MHz; bRecorded in CDCl3 at 600 
MHz. 
Table 1. 13C NMR data for boledulins A–C (1–3). 
position 1a 2b 3b 
1 61.3, CH 44.2, CH 48.4, CH 
2 29.9, CH 33.1, CH 31.7, CH 
3 43.6, CH2 37.9, CH2 44.8, CH2 
4 70.2, CH 67.3, CH 70.4, CH 
5 68.4, CH 150.9, C 65.8, CH 
6 36.7, qC 44.9, qC 37.7, qC 
7 53.0, CH2 51.5, CH2 56.6, CH2 
8 49.4, qC 50.3, qC 129.4, qC 
9 87.8, qC 136.4, qC 131.4, qC 
10 174.6, qC 175.3, qC 60.5, CH2 
11 21.1, CH3 19.4, CH3 20.0, CH3 
12 28.3, CH3 30.1, CH3 24.8, CH3 
13 36.3, CH3 30.6, CH3 31.2, CH3 
14 21.8, CH3 23.6, CH3 15.0, CH3 
15 78.0, CH2 68.6, CH2  
COOCH3 51.6, CH3 52.3, CH3  
OCH3 59.4, CH3   
aMeasured in CDCl3 at 100 MHz; 
bMeasured in CDCl3 at 150 MHz. 
 
Figure 1.  Selected 2D NMR correlations of 1 and 3. 
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of δH 2.05 and 2.19 (each 1H, d, J = 16.8 Hz, H-7a and H-7b, 
respectively) with C 129.4 (s, C-8) suggested a double bond 
between C-8 and C-9, which was derived from the degradation 
of a carbon at C-8. Analysis of other 1D and 2D NMR data 
established ring B as depicted in Figure 1. Therefore, 
compound 3 was established to be a 15-nor-botryane 
sesquiterpenoid and named as boledulin C. 
All compounds were evaluated for their cytotoxicities against 
five human cancer cell lines using the MTT method as 
reported previously.7 The result displayed that compound 1 
showed moderate cytotoxicity against five human cancer cell 
lines using cisplatin as the positive control, while compounds 
2–3 were inactive against all the tested cell lines with IC50 
values of more than 40 M (Table 3). 
 
Experimental Section 
General Experimental Procedures. Optical rotations were 
measured with a Jasco P-1020 polarimeter. IR spectra were 
obtained on a Bruker FT-IR Tensor 27 spectrometer using KBr 
pellets. 1D and 2D NMR spectra were run on an AV-400 MHz 
or a Bruker avance III-600 MHz spectrometer with TMS as an 
internal standard. Chemical shifts () were expressed in ppm 
with reference to solvent signals. HREIMS were recorded on a 
Waters Auto Premier P776 spectrometer. HRESIMS were 
recorded on an API QSTAR Pulsar i spectrometer. Column 
chromatography (CC) was performed on silica gel (200-300 
mesh, Qingdao Marine Chemical Ltd., Qingdao, People’s 
Republic of China). An Agilent 1100 series instrument 
equipped with Agilent ZORBAX SB-C18 column (5 μm, 4.6 
mm × 150 mm) was used for high-performance liquid 
chromatography (HPLC) analysis, and a semipreparative 
Agilent ZORBAX SB-C18 column (5 μm, 9.4 mm × 150 mm) 
was used for the sample preparation. Fractions were monitored 
by TLC (GF 254, Qingdao Haiyang Chemical Co., Ltd. 
Qingdao), and spots were visualized by 10% H2SO4 in ethanol. 
 
Fungal Material and Cultivation Conditions. The fungi 
Boletus edulis Bull. were collected from Ailao Mountain, 
Yunnan province, China. A voucher specimen was deposited 
at State Key Laboratory of Phytochemistry and Plant 
Resources in West China, Kunming Institute of Botany, 
Chinese Academy of Sciences. The mycelial cultures were 
derived from tissue plugs. Culture PDA medium: potato 
(peeled), 200 g, glucose, 20 g, KH2PO4, 3 g, MgSO4, 1.5 g, 
citric acid, 0.1 g, and thiamin hydrochloride, 10 mg, in 1 L of 
deionized H2O. The pH was adjusted to 6.5 before autoclaving, 
and the fermentation was carried out on a shaker at 25 °C and 
150 rpm for 20 days. 
 
Extraction and Isolation. The culture broth (20 L) was 
extracted three times with EtOAc. The EtOAc lay was 
evaporated in vacuo to yield an extract (8.6 g). The latter was 
subjected to a silica gel column eluted with petroleum ether-
acetone (1:0 to 0:1) to afford fractions1–5. Fraction 2 (1.8 g) 
was separated by silica gel CC (petroleum ether-Me2CO, 10:1 
 3:1) to afford two subfractions a and b. Fraction a (100 mg) 
was separated repeatedly by silica gel CC (petroleum ether-
EtOAc, 7:1) to afford 3 (10.5 mg). Fraction b (30 mg) was 
separated further by HPLC (acetonitrile-H2O, 40:60 to 60:40) 
to yield 1 (2.2 mg) and 2 (1.1 mg). 
 
Boledulin A (1): white solid; [α]20D + 16.8 (c 0.19, CHCl3); 
IR (KBr) max 3439, 2924, 2855, 1729, 1629, 1177, 1088 cm−1; 
13C (150 MHz) and 1H NMR (600 MHz) data (CDCl3), see 
Tables 1 and 2, respectively; positive ion HRESIMS m/z 
337.1990 (calcd for C17H30O5Na [M + Na]+, 337.1990). 
 
Boledulin B (2): colorless oil; [α]20D + 10.3 (c 0.17, CHCl3); 
13C (150 MHz) and 1H NMR (600 MHz) data (CDCl3), see 
Tables 1 and 2, respectively; positive ion HRESIMS m/z 
305.1720 (calcd for C16H26O4Na [M + Na]+, 305.1728). 
 
Boledulin C (3): white solid; [α]20D  1.0 (c 0.18, CHCl3); IR 
(KBr) max 3251, 2977, 2828, 1699, 1442, 1361, 1037 cm−1; 
13C (100 MHz) and 1H NMR (400 MHz) data (CDCl3), see 
Tables 1 and 2, respectively; HREIMS m/z 224.1765 (calcd for 
C14H24O2 [M]+, 224.1776). 
 
Cytotoxicity Assay. Five human cancer cell lines, breast 
cancer MCF-7, hepatocellular carcinoma SMMC-7721, human 
myeloid leukemia HL-60, colon cancer SW480, and lung 
cancer A-549 cells, were used in the cytotoxic assay. All the 
cells were cultured in RPMI-1640 or DMEM medium 
(Hyclone, USA), supplemented with 10% fetal bovine serum 
(Hyclone, USA) in 5% CO2 at 37 C. The cytotoxicity assay 
was performed according to the MTT (3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyl tetrazolium bromide) method in 96-well 
microplates.7 Briefly, 100 µL adherent cells were seeded into 
each well of 96-well cell culture plates and allowed to adhere 
for 12 h before drug addition, while suspended cells were 
seeded just before drug addition with initial density of 1 × 105 
cells/mL. Each tumor cell line was exposed to the test 
compound dissolved in DMSO at concentrations of 0.0625, 
0.32, 1.6, 8, and 40 μmol in triplicates for 48 h, with cisplatin 
(Sigma, USA) and taxol (National Institute for the Control of 
Pharmaceutical and Biological Products, P. R. China) as 
positive controls. After compound treatment, cell viability was 
detected and a cell growth curve was graphed. IC50 values 
were calculated by Reed and Muench’s method.8 
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Table 3. Cytotoxicity for Boledulins A-C (1-3) (IC50, μM). 
Compd. HL-60 SMMC-7721 A-549 MCF-7 SW480 
1 2.6 8.4 8.3 3.4 3.5 
2 > 40 > 40 > 40 > 40 > 40 
3 > 40 > 40 > 40 > 40 > 40 
cisplatin 1.1 14.5  12.8  13.0  12.6  
taxol < 0.008 < 0.008 < 0.008 < 0.008 < 0.008 
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